Thalidomide-O-amide-C5-NH2 is primarily utilized in the field of medicinal chemistry and drug development due to its potential therapeutic properties. It is often explored as a derivative of thalidomide, which is known for its immunomodulatory and anti-inflammatory effects. This compound is particularly investigated for its ability to inhibit tumor necrosis factor-alpha (TNF-α) and its role in targeting specific proteins involved in cancer progression, such as cereblon. Researchers are also studying its application in treating conditions like multiple myeloma, leprosy, and other inflammatory diseases. Additionally, its modified structure may enhance bioavailability and reduce side effects, making it a promising candidate for further clinical research.